The Patent Finder

Tragara Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Tragara Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Tragara Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,120,815Solid state forms of macrocyclic kinase inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,544,162Polymorphic Form of TG02
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,043,630Polymorphic Form of TG02 for Treating Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,865,116Treatment of Cancer with TG02
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,247,423Methods and Compositions for the Treatment of Cancer, Tumors, and Tumor-Related Disorders
Formerly held
Lapsed on the fee record
Ended Aug 21, 2016 · High confidence
Lapsed on the fee recordEnded Aug 21, 2016High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited